巨头争相入局 竞逐千亿级医美赛道

经济参考报
09 Jul

近段时间,接连有医药企业、跨界大佬争相“杀入”医美赛道。曾连续4年蝉联《福布斯》“中国内地富豪榜”榜首的钟睒睒34亿元入股锦波生物;昊海生科与华润系企业达成战略合作;九州通收购*ST美谷……随着多方资本的加入和相关产品的创新迭代,医美行业竞争态势正在发生变化。业内人士分析认为,具有“合规化”基因、研产销全产业链布局、丰富产品布局的企业有望取得优势。  钟睒睒旗下公司入股锦波生物  锦波生物日前公告...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10